FDA Is Inaccurately Using Incomplete Safety Data On CBD To Refuse Regulation, Says Hemp Non-Profit
The hemp industry’s national advocacy organization, the U.S. Hemp Roundtable is not pleased with the recent Food and Drug Administration's presentation of a potential CBD framework.
